The Senate Health, Education, Labor and Pensions Committee today held a hearing on the opioid crisis and “how to move forward.” Journalist Sam Quinones, author of the book “Dreamland: The True Tale of America’s Opiate Epidemic,” shared his recommendations for addressing the crisis, which included greater use of innovative community and law enforcement solutions, promoting a wider array of pain strategies by physicians, and urging insurance companies to reimburse for non-narcotic pain treatments. “CARA and the Cures Act make up a great start…but they are only a start,” Quinones said. “Everything I’ve learned about this issue has taught me the importance of long-term community responses and commitment.” In a statement submitted for an October hearing on the issue, AHA urged the committee to eliminate barriers to treatment created by the Medicaid Institutions for Mental Disease exclusion; align Part 2 federal regulations governing the confidentiality of substance use disorder treatment records with the Health Insurance Portability and Accountability Act; enhance access to medication-assisted treatment; and strengthen and ensure prescription drug monitoring programs can share information across state lines, among other actions.

Related News Articles

Headline
The proportion of hospital emergency department visits by uninsured patients declined 2.1 percentage points per year between 2014 and 2016, just after the…
Headline
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the…
Headline
April 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Headline
The Centers for Medicare…
Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV…